Repetitive nasal allergen challenge in allergic rhinitis: Priming and Th2-type inflammation but no evidence of remodelling

Clin Exp Allergy. 2021 Feb;51(2):329-338. doi: 10.1111/cea.13775. Epub 2020 Nov 30.

Abstract

Background: Local tissue eosinophilia and Th2 cytokines are characteristic features of seasonal allergic rhinitis. Airway remodelling is a feature of asthma whereas evidence for remodelling in allergic rhinitis (AR) is conflicting.

Objective: By use of a novel human repetitive nasal allergen challenge (RAC) model, we evaluated the relationship between allergic inflammation and features of remodelling in AR.

Methods: Twelve patients with moderate-severe AR underwent 5 alternate day challenges with diluent which after 4 weeks were followed by 5 alternate day challenges with grass pollen extract. Nasal symptoms, Th1/Th2 cytokines in nasal secretion and serum were evaluated. Nasal biopsies were taken 24 hours after the 1st and 5th challenges with diluent and with allergen. Sixteen healthy controls underwent a single challenge with diluent and with allergen. Using immunohistochemistry, epithelial and submucosal inflammatory cells and remodelling markers were evaluated by computed image analysis.

Results: There was an increase in early and late-phase symptoms after every allergen challenge compared to diluent (both P < .05) with evidence of both clinical and immunological priming. Nasal tissue eosinophils and IL-5 in nasal secretion increased significantly after RAC compared to corresponding diluent challenges (P < .01, P = .01, respectively). There was a correlation between submucosal mast cells and the early-phase clinical response (r = 0.79, P = .007) and an association between epithelial eosinophils and IL-5 concentrations in nasal secretion (r = 0.69, P = .06) in allergic rhinitis. No differences were observed after RAC with regard to epithelial integrity, reticular basement membrane thickness, glandular area, expression of markers of activation of airway remodelling including α-SMA, HSP-47, extracellular matrix (MMP7, 9 and TIMP-1), angiogenesis and lymphangiogenesis for AR compared with healthy controls.

Conclusion: Novel repetitive nasal allergen challenge in participants with severe persistent seasonal allergic rhinitis resulted in tissue eosinophilia and increases in IL-5 but no structural changes. Our data support no link between robust Th2-inflammation and development of airway remodelling in AR.

Keywords: allergic rhinitis; angiogenesis; early- and late-phase response; eosinophils; inflammation; lymphangiogenesis; mast cells; priming; remodelling; repetitive allergen challenge; rhinitis.

MeSH terms

  • Actins / metabolism
  • Adult
  • Airway Remodeling / immunology*
  • Allergens / administration & dosage
  • Diagnostic Techniques, Respiratory System
  • Eosinophilia / immunology
  • Female
  • HSP47 Heat-Shock Proteins / metabolism
  • Humans
  • Inflammation / immunology*
  • Interleukin-5 / immunology
  • Male
  • Matrix Metalloproteinase 7 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Nasal Mucosa / metabolism*
  • Nasal Mucosa / pathology
  • Plant Extracts / administration & dosage
  • Poaceae / immunology*
  • Pollen / immunology*
  • Rhinitis, Allergic / immunology*
  • Rhinitis, Allergic / pathology
  • Rhinitis, Allergic, Seasonal / immunology*
  • Rhinitis, Allergic, Seasonal / pathology
  • Severity of Illness Index
  • Th2 Cells / immunology
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Young Adult

Substances

  • ACTA2 protein, human
  • Actins
  • Allergens
  • HSP47 Heat-Shock Proteins
  • Interleukin-5
  • Plant Extracts
  • SERPINH1 protein, human
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • MMP7 protein, human
  • Matrix Metalloproteinase 7
  • MMP9 protein, human
  • Matrix Metalloproteinase 9